CURRENT VIEWS ON ABDOMINAL ADHESIONS IN TUBOPERITONEAL INFERTILITY


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Background. One of the main causes of infertility is small pelvic adhesions that are induced by a set of various factors and result in tuboperitoneal infertility. Case description. The paper describes the experience in choosing combination therapy for a patient with obstruction of both fallopian tubes after laparoscopic salpingolysis. Pregnancy was recorded 3 months after treatment. Conclusion. It is necessary to perform combination therapy for inflammatory diseases and conditions in the period after surgery using drugs that can reduce the formation of adhesions in the small pelvis. For this purpose, longidase can be considered as the drug of choice.

Texto integral

Acesso é fechado

Sobre autores

Lyudmila Smirnova

PhD, Department of Obstetrics and Gynecology, Assistant Faculty of Dentistry, MSMSU. 127473, Russia, Moscow, Delegatskaya str. 20, bld. 1

Madina Umakhanova

MD, Professor of Obstetrics and Gynecology, Faculty of Dentistry, MSMSU 127473, Russia, Moscow, Delegatskaya str. 20, bld. 1

Amirhan Torchinov

MD, professor, Department of Obstetrics and Gynecology, Faculty of Dentistry, MSMSU. 127473, Russia, Moscow, Delegatskaya str. 20, bld. 1

Bibliografia

  1. Балан В.Е., Журавель А.С. Возможности применения препаратов, содержащих гиалуроновую кислоту в гинекологии. Эффективная фармакотерапия. 2014; 23: 50-5. [Balan V.E., Zhuravel A.S. The possibilities of application of preparations containing hyaluronic acid in gynecology. Effektivnaya farmakoterapiya. 2014; 23: 50-5.
  2. Пахилова Е.В., Синчихин С.П., Мамиев О.Б., Буров А.В. Некоторые современные аспекты этиологии, клинической картины и лечения острых воспалительных заболеваний придатков матки. Гинекология. 2010; 12(5): 20-4. [Pakhilova E.V., Sinchikhin S.P., Mamiev O.B., Burov A.V. Some modern aspects of etiology, clinical presentation, and treatment of acute inflammatory diseases of the uterus. Ginekologiya. 2010; 12(5): 20-4.
  3. Прилепская В.Н., Яглов В.В. Воспалительные заболевания органов малого таза. М.: ГЭОТАР-Медиа; 2010. [Prilepskaya V.N., Yaglov V.V. Inflammatory diseases of the pelvic organs. Moscow: GEOTAR-Media; 2010.
  4. Петрович Е.А., Колесов А.А., Манухин И.Б. Безопасность и эффективность препарата Лонгидазы 3000 МЕ при лечении больных, страдающих спаечным процессом в малом тазе. Иммунология. 2006; 27(2): 124-6. [Petrovich E.A., Kolesov A.A., Manuhin I.B. The safety and efficacy of the drug Longidaza 3000 IU for the treatment of patients with adhesive process in small pelvis. Immunologiya. 2006; 27(2): 124-6.
  5. Ковалева Л.А. Возможности ферментной терапии при хронических воспалительных заболеваниях органов малого таза. Русский медицинский журнал. 2010; 18(19): 1162-4. [Kovaleva L.A. The possibilities of enzyme therapy for chronic inflammatory diseases of the pelvic organs. Russkiy meditsinskiy zhurnal. 2010; 18(19): 1162-4.
  6. Некрасов А.В., Пучкова Н.Г., Карапутадзе Н.Т. Физико-химические принципы создания Лонгидазы. Иммунология. 2006; 27(2): 114 8 [Nekrasov A.V., Puchkova N.G., Karaputadze N.T. Physico-chemical principles of Longidaza creation. Immunologiya. 2006; 27(2): 114-8.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © ООО «Бионика Медиа», 2016

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies